EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization
What You Should Know:
– EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access.
– The merger combines Waltz Health’s…
Continue Reading
